These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


272 related items for PubMed ID: 12176229

  • 1. Production of spherical pellets by a hot-melt extrusion and spheronization process.
    Young CR, Koleng JJ, McGinity JW.
    Int J Pharm; 2002 Aug 21; 242(1-2):87-92. PubMed ID: 12176229
    [Abstract] [Full Text] [Related]

  • 2. Properties of drug-containing spherical pellets produced by a hot-melt extrusion and spheronization process.
    Young CR, Koleng JJ, McGinity JW.
    J Microencapsul; 2003 Aug 21; 20(5):613-25. PubMed ID: 12909545
    [Abstract] [Full Text] [Related]

  • 3. Physicochemical properties of film-coated melt-extruded pellets.
    Young CR, Crowley M, Dietzsch C, McGinity JW.
    J Microencapsul; 2007 Feb 21; 24(1):57-71. PubMed ID: 17438942
    [Abstract] [Full Text] [Related]

  • 4. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr 21; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 5. Compression of controlled-release pellets produced by a hot-melt extrusion and spheronization process.
    Young CR, Dietzsch C, McGinity JW.
    Pharm Dev Technol; 2005 Apr 21; 10(1):133-9. PubMed ID: 15776821
    [Abstract] [Full Text] [Related]

  • 6. Properties of melt extruded enteric matrix pellets.
    Schilling SU, Shah NH, Waseem Malick A, McGinity JW.
    Eur J Pharm Biopharm; 2010 Feb 21; 74(2):352-61. PubMed ID: 19782133
    [Abstract] [Full Text] [Related]

  • 7. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR, Dietzsch C, Cerea M, Farrell T, Fegely KA, Rajabi-Siahboomi A, McGinity JW.
    Int J Pharm; 2005 Sep 14; 301(1-2):112-20. PubMed ID: 16055285
    [Abstract] [Full Text] [Related]

  • 8. Influence of the drying technique on theophylline pellets prepared by extrusion-spheronization.
    Pérez J, Rabisková M.
    Int J Pharm; 2002 Aug 21; 242(1-2):349-51. PubMed ID: 12176277
    [Abstract] [Full Text] [Related]

  • 9. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
    Roblegg E, Jäger E, Hodzic A, Koscher G, Mohr S, Zimmer A, Khinast J.
    Eur J Pharm Biopharm; 2011 Nov 21; 79(3):635-45. PubMed ID: 21801834
    [Abstract] [Full Text] [Related]

  • 10. Novel application of hot-melt extrusion for the preparation of monolithic matrices containing enteric-coated particles.
    Schilling SU, McGinity JW.
    Int J Pharm; 2010 Nov 15; 400(1-2):24-31. PubMed ID: 20727956
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of the stability of venlafaxine hydrochloride sustained-release pellets prepared by double-polymer coatings and hot-melt subcoating combined with Eudragit(®) NE30D outercoating.
    Guan T, Wang J, Li G, Tang X.
    Pharm Dev Technol; 2011 Jun 15; 16(3):269-77. PubMed ID: 20214529
    [Abstract] [Full Text] [Related]

  • 12. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
    Zhu Y, Mehta KA, McGinity JW.
    Pharm Dev Technol; 2006 Jun 15; 11(3):285-94. PubMed ID: 16895839
    [Abstract] [Full Text] [Related]

  • 13. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).
    Zhang F, McGinity JW.
    Drug Dev Ind Pharm; 2000 Sep 15; 26(9):931-42. PubMed ID: 10914317
    [Abstract] [Full Text] [Related]

  • 14. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D, Zheng W, Coots LB, McGinity JW.
    Eur J Pharm Biopharm; 2007 Sep 15; 67(2):464-75. PubMed ID: 17451929
    [Abstract] [Full Text] [Related]

  • 15. Influence of plasticizer type and level on the properties of Eudragit S100 matrix pellets prepared by hot-melt extrusion.
    Schilling SU, Lirola HL, Shah NH, Waseem Malick A, McGinity JW.
    J Microencapsul; 2010 Sep 15; 27(6):521-32. PubMed ID: 20575612
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Co-processed MCC-Eudragit® E excipients for extrusion-spheronization.
    Goyanes A, Souto C, Martínez-Pacheco R.
    Eur J Pharm Biopharm; 2011 Nov 15; 79(3):658-63. PubMed ID: 21827853
    [Abstract] [Full Text] [Related]

  • 20. Bi-layered self-emulsifying pellets prepared by co-extrusion and spheronization: influence of formulation variables and preliminary study on the in vivo absorption.
    Iosio T, Voinovich D, Grassi M, Pinto JF, Perissutti B, Zacchigna M, Quintavalle U, Serdoz F.
    Eur J Pharm Biopharm; 2008 Jun 15; 69(2):686-97. PubMed ID: 18191390
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.